PI
BMY icon

PEAK6 Investments’s Bristol-Myers Squibb BMY Stock Holding History

PEAK6 Investments’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$6.22M Sell
120,168
-13,618
-10% -$639K 0.01% 820
2024
Q2 		$5.56M Buy
133,786
+95,573
+250% +$4.28M 0.01% 792
2024
Q1 		$2.07M Sell
38,213
-32,045
-46% -$1.63M 0.01% 1405
2023
Q4 		$3.6M Buy
+70,258
New +$3.69M 0.01% 1071
2023
Q3 		– Sell
-58,902
Closed -$3.61M – 4073
2023
Q2 		$3.77M Buy
58,902
+52,405
+807% +$3.51M 0.02% 801
2023
Q1 		$450K Sell
6,497
-193,458
-97% -$13.6M ﹤0.01% 2481
2022
Q4 		$14.4M Buy
199,955
+118,061
+144% +$8.9M 0.08% 249
2022
Q3 		$5.82M Buy
81,894
+22,992
+39% +$1.67M 0.02% 739
2022
Q2 		$3.77M Buy
+58,902
New +$4.49M 0.02% 802
2022
Q1 		– Sell
-44,478
Closed -$2.99M – 5226
2021
Q4 		$2.77M Sell
44,478
-317,844
-88% -$18.6M 0.01% 1598
2021
Q3 		$21.4M Buy
362,322
+89,779
+33% +$5.91M 0.05% 361
2021
Q2 		$18.2M Sell
272,543
-67,467
-20% -$4.4M 0.04% 403
2021
Q1 		$21.5M Buy
340,010
+282,979
+496% +$17.6M 0.05% 327
2020
Q4 		$3.54M Buy
+57,031
New +$3.51M 0.01% 1364
2020
Q2 		– Sell
-384,375
Closed -$23M – 4376
2020
Q1 		$21.4M Buy
384,375
+323,335
+530% +$19.8M 0.13% 149
2019
Q4 		$3.92M Buy
+61,040
New +$3.5M 0.02% 739
2019
Q3 		– Sell
-208,849
Closed -$9.82M – 3751
2019
Q2 		$9.47M Sell
208,849
-55,713
-21% -$2.6M 0.06% 385
2019
Q1 		$12.6M Buy
264,562
+162,340
+159% +$8.09M 0.07% 287
2018
Q4 		$5.31M Buy
+102,222
New +$5.49M 0.03% 599

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

PEAK6 Investments's BMY Position: Q3 2024 in Review

PEAK6 Investments reduced its Bristol-Myers Squibb (BMY) stake by 10% in Q3 2024, selling an estimated $639K and leaving 120,168 shares worth $6.22M. The position accounts for 0.01% of the portfolio, ranked #820.

PEAK6 Investments first reported a position in BMY in Q4 2018 and has held it in 19 quarters since. The position peaked at $21.5M in Q1 2021. 2,263 funds tracked by Wall St. Rank hold BMY as of Q3 2024.

  • PEAK6 Investments held 120,168 shares of Bristol-Myers Squibb worth $6.22M as of Q3 2024.
  • PEAK6 Investments sold 13,618 Bristol-Myers Squibb shares in Q3 2024, an estimated $639K.
  • Bristol-Myers Squibb made up 0.01% of PEAK6 Investments's portfolio in Q3 2024, its #820 holding.
  • PEAK6 Investments first reported a position in Bristol-Myers Squibb in Q4 2018 and has held it in 19 quarters since.
  • PEAK6 Investments's Bristol-Myers Squibb position peaked at $21.5M in Q1 2021.
  • 2,263 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2024.

Based on PEAK6 Investments's 13F filing for Q3 2024, filed 14 Nov 2024.